Michael E. Farkouh, MD, MSc, Named Associate Dean for Research and Clinical Trials

Cedars-Sinai has appointed Michael E. Farkouh, MD, MSc, as associate dean for Research and Clinical Trials and professor of Cardiology, effective March 1, 2023. A clinical cardiologist and epidemiologist, Farkouh is internationally known for his academic leadership and distinguished record of diabetes and cardiovascular disease clinical trials.

Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center Network

The Pulmonary Fibrosis Foundation has named Cedars-Sinai part of its Care Center Network, a group of medical centers that have demonstrated expertise in treating and supporting people with this deadly disease.

Stroke, Clot Risk Halved in Heart Disease and Arrhythmia Patients Who Took Blood Thinners Apixaban Versus Rivaroxaban

The new study showed apixaban is superior to rivaroxaban against stroke or systemic embolism in patients with atrial fibrillation and valvular heart disease

Icahn School of Medicine at Mount Sinai Receives National Institutes of Health Award to Accelerate Development of New Treatments

The Icahn School of Medicine at Mount Sinai has been awarded a five-year, $55.5 million grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Program that will benefit the diverse patient population Mount Sinai serves by accelerating the development of new treatments for leading health conditions, including cardiorespiratory and psychiatric disorders, diabetes, malignancies, and infectious diseases.

With awards totaling $446M, UIC sets record for annual research funding 

The University of Illinois Chicago received $446 million in sponsored funding during the 2021 fiscal year, setting a record for research awards.  The total amount represents an 8.6% increase over fiscal year 2020, with funding supporting over 3,500 research projects that move research to practical application.

WHERE TROUBLE STARTS

In the earliest hours of your embryonic status, cells were developing and multiplying, critical processes were starting up, networks were connecting and genetic codes — for better or worse — were directing the whole project.

That early development is the focus of University of Delaware biologist Shuo Wei’s research. Now his work has won more than $1.8 million in support from the National Institutes of Health.

Endocrine Society urges Congress to increase funding for NIH

The Endocrine Society—the world’s largest professional organization for endocrine scientists and physicians—is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns.

Mount Sinai Study Finds First Cases of COVID-19 in New York City are Primarily from European and US Sources

First definitive molecular epidemiology study of SARS-CoV-2 in New York City to describe the route by which the virus arrived

Supercomputer Helps Benchmark Cancer Immunotherapy Tool

With an estimated 1.7 million new cases and 600,000 deaths during 2017 in the U.S. alone, cancer remains a critical healthcare challenge. Researchers used the Comet supercomputer at the San Diego Supercomputer Center (SDSC) to evaluate their new molecular docking tool which aims to improve immunotherapy outcomes by identifying more effective personalized treatments.

Funerals Pose Challenges Amid ‘Social Distancing’ and Travel Restrictions During the COVID-19 Pandemic

While a huge focus is on health and mortality during the coronavirus outbreak, not to be forgotten are those who are grappling with death from natural causes, diseases, accidents and crime. Funerals and visitations are the customary means of support friends and loved ones — but restricted travel and social distancing poses challenges.

House Drug Pricing Bill Serves Patients, Public Health

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.